Xenon does not prolong neuromuscular block of rocuronium

Anesthesia and Analgesia

Volumn 99, Issue 5, 2004, Pages 1398-1401

  Kunitz, Oliver ^a   Baumert, Jan Hinrich ^a   Hecker, Klaus ^a   Beeker, Thorben ^a   Coburn, Mark ^a   Zühlsdorff, André ^a   Rossain, Rolf ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MIDAZOLAM; PROPOFOL; REMIFENTANIL; ROCURONIUM; XENON;

ADULT; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ARTICLE; BISPECTRAL INDEX; BLOOD GAS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ELECTROMYOGRAPHY; FEMALE; HUMAN; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NEUROMUSCULAR BLOCKING; PARTITION COEFFICIENT; PHARMACODYNAMICS; PHARMACOKINETICS; PREMEDICATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANDROSTANOLS; ANESTHESIA RECOVERY PERIOD; ANESTHESIA, INHALATION; ANESTHESIA, INTRAVENOUS; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDAZOLAM; MIDDLE AGED; MONITORING, INTRAOPERATIVE; MUSCLE, SKELETAL; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PREANESTHETIC MEDICATION; PROPOFOL; XENON;

EID: 6444233483     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000132970.64413.E7     Document Type: Article

References (21)

1. Bock M, Klippel K, Nitsche B, et al. Rocuronium potency and recovery characteristics during steady-state desflurane, sevoflurane, isoflurane or propofol anaesthesia. Br J Anaesth 2000;84:43-7.
2. Jellish WS, Brody M, Sawicki K, Slogoff S. Recovery from neuromuscular blockade after either bolus and prolonged infusions of cisatracurium or rocuronium using either isoflurane or propofol-based anesthetics. Anesth Analg 2000;91:1250-5.
3. Goto T, Suwa K, Uezono S, et al. The blood-gas partition coefficient of xenon may be lower than generally accepted. Br J Anaesth 1998;80:255-6.
4. Nakata Y, Goto T, Ishiguro Y, et al. Minimum alveolar concentration (MAC) of xenon with sevoflurane in humans. Anesthesiology 2001;94:611-4.
5. Rossaint R, Reyle-Hahn M, Schulte Am Esch J, et al. Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgery. Anesthesiology 2003;98:6-13.
6. Homi HM. The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. Anesthesiology 2003;99:876-81.
7. Huneke RMD. Effects of the anesthetic gases xenon, halothane, and isoflurane on calcium and potassium currents in human atrial cardiomyocytes. Anesthesiology 2001;95:999-1006.
8. Petzelt C, Blom P, Schmehl W, et al. Prevention of neurotoxicity in hypoxic cortical neurons by the noble gas xenon. Life Sci 2003;72:1909-18.
9. Schroth SC, Schotten U, Alkanoglu O, et al. Xenon does not impair the responsiveness of cardiac muscle bundles to positive inotropic and chronotropic stimulation. Anesthesiology 2002;96:422-7.
10. Viby-Mogensen J, Englbaek J, Eriksson LI, et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996;40:59-74.
11. Singh H. Bispectral index (BIS) monitoring during propofol-induced sedation and anaesthesia. Eur J Anaesthesiol 1999;16:31-6.
12. Tenbrinck R, Leendertse K, Erdmann W. Xenon in the PhysioFlex: the first clinical experience. Association for Low Flow Anaesthesia. Gent 1998 1998;3:6-7.
13. Lowry DW, Mirakhur RK, Carroll MT, et al. Potency and time course of mivacurium block during sevoflurane, isoflurane and intravenous anesthesia. Can J Anaesth 1999;46:29-33.
14. Englbaek J, Skovgaard LT, Friis B, et al. Monitoring of neuromuscular transmission by electromyography: stability and temperature dependence of evoked EMG response compared to mechanical twitch recordings in the cat. Acta Anaesthesiol Scand 1992;36:495-504.
15. Viby-Mogensen J, Jensen E, Werner M, Nielsen HK. Measurement of acceleration: a new method of monitoring neuromuscular function. Acta Anaesthesiol Scand 1988;32:45-8.
16. Nakata Y, Goto T, Saito G, et al. Comparison of acceleromyography and electromyography in vecuronium-induced neuromuscular blockade with xenon or sevoflurane anesthesia. J Clin Anesth 1998;10:200-3.
17. Lerman J, Schmitt-Bantel B, Gregory GA, et al. Effect of age on the solubility of volatile anesthetics in human tissues. Anesthesiology 1986;65:307-11.
18. Yeh S, Peterson R. Solubility of krypton and xenon in blood, protein solutions, and tissue homogenates. J Appl Physiol 1965;20:1041-7.
19. Zhou J-X, Liu J. The effect of temperature on solubility of volatile anesthetics in human tissues. Anesth Analg 2001;93:234-8.
20. Kunitz O, Baumert HJ, Hecker K, et al. Influence of xenon on onset-time, duration and recovery of mivacurium induced neuromuscular block. Eur J Anaesthesiol 2003;20:124-5.
21. Nakata Y, Goto T, Morita S. Vecuronium-induced neuromuscular block during xenon or sevoflurane anaesthesia in humans. Br J Anaesth 1998;80:238-40.